Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05344833
Title Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma
Acronym HEME-18
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Illinois at Chicago
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois at Chicago RECRUITING Chicago Illinois 60612 United States Details
*Shaded cells indicate that there was no data available from for the field